Ali J. Satvat insider trades

Open-market stock purchases and sales by Ali J. Satvat, Director at BridgeBio Pharma, Inc, from SEC Form 4 filings since Nov 6, 2014.

Recent trades

DateStockTradeValue
Jun 22, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 22, 2026BBIO BridgeBio Pharma, IncBought (not open market)—
Jun 5, 2026CHRS Coherus Oncology, IncBought (not open market)—
Jun 5, 2026CHRS Coherus Oncology, IncBought (not open market)—

Companies traded

  • BBIO BridgeBio Pharma, Inc: other filings, last Jun 22, 2026
  • CHRS Coherus Oncology, Inc: other filings, last Jun 5, 2026
  • EIDX Eidos Therapeutics, Inc: 3 buys, last Jan 26, 2021

Get free alerts when Ali J. Satvat files a new trade →